Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: billkirn who wrote (4528)	6/18/1998 1:35:00 AM
From: billkirn	Respond to of 6136

Found from a Margie post... Some quotes by Peter Johnson reported in the Tribune in February 1997, before Viracept approval: "It's been our experience that managing expectations is so important," says Johnson. "Particularly when you're dealing with diseases where there's a lot of emotions associated -- with AIDS, with cancer -- the last thing somebody needs is building unrealistic expectations or building expectations too early." "It's not appropriate to call drugs like these cures, and there aren't any real cures on the radar scope," says Johnson."